AD is characterized by abnormal accumulation of amyloid β (Aβ) and hyperphosphorylated tau protein (p-Tau), the typical development of predominantly episodic memory-related symptoms, followed by impairment in other cognitive domains (Lane et al., 2018). Here, MAPT is linked to Alzheimer disease.